Remdesivir News and Research

RSS
Potential therapy candidates for patients infected with the SARS-CoV-2 Omicron variant

Potential therapy candidates for patients infected with the SARS-CoV-2 Omicron variant

New trial tests the effectiveness of hyperimmune immunoglobulin for hospitalized COVID-19 patients

New trial tests the effectiveness of hyperimmune immunoglobulin for hospitalized COVID-19 patients

Hospitalized COVID-19 patients may derive modest benefit from convalescent plasma, study shows

Hospitalized COVID-19 patients may derive modest benefit from convalescent plasma, study shows

Study explains why Omicron infections are less likely to cause severe disease

Study explains why Omicron infections are less likely to cause severe disease

Nirmatrelvir, Molnupiravir, and Remdesivir hold-up against SARS-CoV-2 Omicron variant in vitro

Nirmatrelvir, Molnupiravir, and Remdesivir hold-up against SARS-CoV-2 Omicron variant in vitro

Patient, beware: Some states still pushing ineffective covid antibody treatments

Patient, beware: Some states still pushing ineffective covid antibody treatments

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

SARS-CoV-2 Omicron infections milder in children compared to Delta

SARS-CoV-2 Omicron infections milder in children compared to Delta

Variants of SARS-CoV-2 and preventive strategies

Variants of SARS-CoV-2 and preventive strategies

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

Macrodomains represent a unique target for pathogens with pandemic potential

Macrodomains represent a unique target for pathogens with pandemic potential

New findings support the routine use of remdesivir in hospitalized COVID-19 patients

New findings support the routine use of remdesivir in hospitalized COVID-19 patients

Topical antiseptic Acriflavine inhibits SARS-CoV-2 and other betacoronaviruses

Topical antiseptic Acriflavine inhibits SARS-CoV-2 and other betacoronaviruses

Impact of post-exposure BNT162b2 prophylaxis against SARS-CoV-2 infections

Impact of post-exposure BNT162b2 prophylaxis against SARS-CoV-2 infections

Lab engineered human A549 lung cell model conducive for investigating SARS-CoV-2 antivirals

Lab engineered human A549 lung cell model conducive for investigating SARS-CoV-2 antivirals

Study identifies current mechanism of action behind reduced severity of Omicron variant COVID-19 infection

Study identifies current mechanism of action behind reduced severity of Omicron variant COVID-19 infection

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

Statistical analysis reveals less severe COVID-19 outcome due to Omicron variant

Statistical analysis reveals less severe COVID-19 outcome due to Omicron variant

In vitro effect of several antiviral drugs against various SARS-CoV-2 variants of concern

In vitro effect of several antiviral drugs against various SARS-CoV-2 variants of concern

Study suggests nitazoxanide fails to reduce the severity of SARS-CoV-2

Study suggests nitazoxanide fails to reduce the severity of SARS-CoV-2